Sentry Investment Management LLC Halozyme Therapeutics, Inc. Transaction History

Sentry Investment Management LLC

  • $238 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$31.82 - $40.75 $619,917 - $793,891
-19,482 Closed
0 $0
Q3 2021

Nov 03, 2021
SELL
$38.47 - $46.42 $58,397 - $70,465
-1,518 Reduced 7.23%
19,482 $793,000
Q2 2021

Aug 04, 2021
BUY
$38.84 - $51.31 $815,640 - $1.08 Million
21,000 New
21,000 $954,000

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Sentry Investment Management LLC Portfolio

Follow Sentry Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email